Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model

International Journal of Medical Microbiology

Volumn 294, Issue 7, 2005, Pages 437-445

  Vanniasinkam, Thiru ^a,b   Barton, Mary D ^a,b   Heuzenroeder, Michael W ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Cell mediated immunity; DNA vaccines; Rhodococcus equi; Th1; VapA

Indexed keywords

BACTERIAL VACCINE; DNA VACCINE; INTERLEUKIN 12; PROTEIN VAPA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL TYPE; CONTROLLED STUDY; FEMALE; HORSE; HOST; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PATHOGENESIS; PLASMID; PROTEIN EXPRESSION; PROVOCATION TEST; RHODOCOCCUS EQUI; TH1 CELL; TREATMENT OUTCOME; VACCINATION;

EID: 12744279208     PISSN: 14384221     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmm.2004.09.011     Document Type: Article

References (31)

1. M.D. Barton, and D.H. Embury Studies of the pathogenesis of Rhodococcus equi infection in foals Aust. Vet. J. 64 1987 332 339
2. J.S. Boyle, J.L. Brady, C. Koniaras, and A.M. Lew Inhibitory effect of lipopolysaccharide on immune response after DNA immunization is route dependent DNA Cell Biol. 17 1998 343 348
3. A. Campos-Neto, J.R. Webb, K. Greeson, R.N. Coler, Y.A. Skeiky, and S.G. Reed Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice Infect. Immun. 70 2002 2828 2836
4. H.W. Chen, C.H. Pan, H.W. Huan, M.Y. Liau, J.R. Chiang, and M.H. Tao Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by co-administration of an IL-12-expressing plasmid J. Immunol. 166 2001 7419 7426
5. A.M. Fontanals, T. Becú, G. Polledo, C.K. Gaskin, and M. Braun Antigenic analysis of Rhodococcus equi preparations using different horse sera Vet. Microbiol. 56 1997 247 255
6. T. Germann, E. Rude, and E. Schmitt The influence of IL12 on the development of Th1 and Th2 cells and its adjuvant effect for humoral immune responses Res. Immunol. 146 1995 481 486
7. S. Ha, D. Kim, K. Baek, Y. Yun, and Y. Sung Il-23 induces stronger sustained CTL and Th1 immune responses than Il-12 in hepatitis C virus envelope protein 2 DNA immunization J. Immunol. 172 2004 525 531
8. K.E. Hooper-McGrevy, S. Giguere, B.N. Wilkie, and J.F. Prescott Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia Am. J. Vet. Res. 62 2001 1307 1313
9. S. Jain, B.R. Bloom, and M.K. Hondalus Deletion of vapA encoding virulence associated protein A attenuates the intracellular actinomycete Rhodococcus equi Mol. Microbiol. 50 2003 115 128
10. S.T. Kanaly, S.A. Hines, and G.H. Palmer Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia Infect. Immun. 63 1995 3037 3041
11. M. Kozak Analysis of ribosome binding sites from the s1 message of reovirus. Initiation at the first and second AUG codons J. Mol. Biol. 156 1982 807 820
12. A.M. Lopez, M.T. Hines, G.H. Palmer, D.C. Alperin, and S.A. Hines Identification of pulmonary T-lymphocyte serum antibody isotype responses associated with protection against Rhodococcus equi Clin. Diagn. Lab. Immunol. 9 2002 1270 1276
13. A.M. Lopez, M.T. Hines, D.P. Palmer, D.C. Alperin, and S.A. Hines Analysis of anamnestic immune responses in adult horses and priming in neonates by a DNA vaccine expressing the vapA gene of Rhodococcus equi Vaccine 21 2003 3815 3825
14. A. Lührmann, N. Mauder, T. Sydor, E. Fernandez-Mora, J. Schulze-Lührmann, S. Takai, and A. Haas Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids Infect. Immun. 72 2004 853 862
15. M. Manthorpe, F. Cornefert-Jensen, J. Hartikka, J. Felgner, A. Rundell, M. Margalith, and V. Dwarki Gene therapy by intramuscular injection of plasmid DNA studies on firefly luciferase gene expression in mice Hum. Gene Ther. 4 1993 419 431
16. T.R. Mosmann, and R.L. Coffman TH1 and TH2 cells different patterns of lymphokine secretion lead to different functional properties Annu. Rev. Immunol. 7 1989 145 173
17. A.Y. Park, and P. Scott Il-12 keeping cell-mediated immunity alive Scand. J. Immunol. 53 2001 529 532
18. J.F. Prescott Rhodococcus equi an animal and human pathogen Clin. Microbiol. Rev. 4 1991 20 34
19. J.F. Prescott, M.C. Patterson, V.M. Nicholson, B. Morein, and J.A. Yager Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice Vet. Microbiol. 56 1997 213 225
20. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning A Laboratory Manual second ed 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA
21. S. Sasaki, F. Takeshita, K.Q. Xin, N. Ishii, and K. Okuda Adjuvant formulations and delivery systems for DNA vaccines Methods 31 2003 243 254
22. T. Sekizaki, S. Takai, Y. Egawa, T. Ikeda, H. Ito, and S. Tsubaki Sequence of the Rhodococcus equi gene encoding the virulence-associated 15-17-kDa antigens Gene 155 1995 135 136
23. R.A. Strugnell, D. Drew, J. Mercieca, S. DiNatale, N. Firez, S.J. Dunstan, C.P. Simmons, and J. Vadolas DNA vaccines for bacterial infections Immunol. Cell Biol. 75 1997 364 369
24. S. Takai, M. Iie, C. Kobayashi, T. Morishita, T. Nishio, T. Ishida, T. Fujimura, Y. Sasaki, and S. Tsubaki Monoclonal antibody specific to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi J. Clin. Microbiol. 31 1993 2780 2782
25. S. Takai, T. Ikeda, Y. Sasaki, Y. Watanabe, T. Ozawa, S. Tsubaki, and T. Sekizaki Identification of virulent Rhodococcus equi by amplification of gene coding for 15-17-kilodalton antigens J. Clin. Microbiol. 33 1995 1624 1627
26. S. Takai, C. Kobayashi, K. Murakami, Y. Sasaki, and S. Tsubaki Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi infection in mice FEMS Immunol. Med. Microbiol. 24 1999 1 9
27. C. Tan, J.F. Prescott, M.C. Patterson, and V.M. Nicholson Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity Can. J. Vet. Res. 59 1995 51 59
28. G. Trinchieri, S. Pflanz, and R.A. Kastelein The IL-12 family of heterodimeric cytokines new players in the regulation of T cell responses Immunity 19 2003 641 644
29. T. Vanniasinkam, M.D. Barton, and M.W. Heuzenroeder The immunogenicity of Rhodococcus equi GroEL2-based vaccines in a murine model Vet. Immunol. Immunopathol. 98 2004 92 100
30. M. Velaz-Faircloth, A.J. Cobb, A.L. Horstman, S.C. Henry, and R. Frothingham Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein Infect. Immun. 67 1999 4243 4250
31. X. Yang, K.T. HayGlass, and R.C. Brunham Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection J. Immunol. 156 1996 4338 4344